Browsing: FDA

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to VER-01, the flagship full-spectrum cannabis drug from Munich-based Vertanical, putting it in…

After being criticised for the insurmountable PMTA process for years, the FDA recently relaxed enforcement on some unauthorised vaping products and approved the first non-tobacco-flavoured vape…

The FDA’s latest guidance on vaping regulation marks a major change in the American nicotine debate. This shift is based more on practical regulation than on…

The recent re-issuance of Modified Risk Tobacco Product (MRTP) authorizations for a number of IQOS heated tobacco devices is yet another milestone in the international tobacco…

A bipartisan coalition of 32 members of Congress is urging federal health officials to expedite ongoing reviews of psychedelic therapies. “For many individuals, current treatment options…

The White House now scheduled a total of four meetings with cannabis industry and research stakeholders this week to discuss a proposed enforcement policy for CBD…

The agency has quietly sent a CBD compliance and enforcement policy to the White House for review, a move that could bring long-overdue standards to a…

The Food and Drug Administration (FDA) has submitted a proposed cannabis products enforcement policy to the White House for review that concerns regulatory issues specifically related…

Vape flavours are one of the most contentious subjects in tobacco harm reduction. Critics argue that flavoured vapes are mainly designed to lure teenagers. But a…